))
Unlocking Site Potential: Reducing Site Burden and Enhancing Clinical Trial Efficiency
Manage episode 371410527 series 3387971
Contenido proporcionado por WCG. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente WCG o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
In the first episode of our new podcast series, WCG Talks Trials, we are joined by three industry experts, Lisa Ballance from Virginia Commonwealth University, John Musser from Florida Cancer Specialists and Research Institute, and Dan Otap from Genentech, to discuss the topic of overcoming site challenges and addressing site burden.
Listen in as we discuss the results of WCG’s recently published 2023 Clinical Research Site Challenges Survey Report, gain insights from our guests on solutions their organizations have implemented to reduce site burden, and share perspectives on how sites, sponsors, and CROs can work to improve site and trial efficiency.
Speakers:
- Sandy Smith, RN, MSN, AOCN
Senior Vice President, Clinical Solutions and Strategic Partnerships at WCG Clinical - Lisa Richman Balance
Associate Vice President for Research Strategy and Regulatory Affairs at Virginia Commonwealth University - John Musser
Senior Director, Clinical Research Administration at Florida Cancer Specialists & Research Institute - Dan Otap
Principal, Alliance and Partnerships Lead at Genentech
71 episodios
Compartir
